Decision of the EEA Joint Committee No 63/2025 of 14 March 2025 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2025/1034]
Date: 2025-03-14
Institutions: EEA Joint Committee
Subjects: European Economic Area, market approval, plant health control, plant health product, revision of an agreement




L_202501034EN.000101.fmx.xml












Official Journal of the European Union


EN
L series













2025/1034


12.6.2025







            DECISION OF THE EEA JOINT COMMITTEE No 63/2025
of 14 March 2025
         
amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2025/1034]


THE EEA JOINT COMMITTEE,

Having regard to the Agreement on the European Economic Area (“the EEA Agreement”), and in particular Article 98 thereof,

Whereas:







(1)


Commission Implementing Regulation (EU) 2024/2221 of 6 September 2024 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances acequinocyl, aluminium silicate, emamectin, fatty acids C7 to C20, pendimethalin, plant oils / rape seed oil and triclopyr (1) is to be incorporated into the EEA Agreement.












(2)


Commission Implementing Regulation (EU) 2024/2390 of 6 September 2024 renewing the approval of the active substance metrafenone in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540/2011 (2) is to be incorporated into the EEA Agreement.












(3)


Annex II to the EEA Agreement should therefore be amended accordingly,





HAS ADOPTED THIS DECISION:



Article 1
Chapter XV of Annex II to the EEA Agreement shall be amended as follows:






1.


The following indents are added in point 13a (Commission Implementing Regulation (EU) No 540/2011):






‘—



32024 R 2221: Commission Implementing Regulation (EU) 2024/2221 of 6 September 2024 (OJ L, 2024/2221, 9.9.2024),










—



32024 R 2390: Commission Implementing Regulation (EU) 2024/2390 of 6 September 2024 (OJ L, 2024/2390, 9.9.2024).’














2.


The following point is inserted after point 13zzzzzzzzzzzzzzw (Commission Implementing Regulation (EU) 2024/2197):






‘13zzzzzzzzzzzzzzx.



32024 R 2390: Commission Implementing Regulation (EU) 2024/2390 of 6 September 2024 renewing the approval of the active substance metrafenone in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540/2011 (OJ L, 2024/2390, 9.9.2024).’










Article 2
The texts of Implementing Regulations (EU) 2024/2221 and (EU) 2024/2390 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic.


Article 3
This Decision shall enter into force on 15 March 2025, provided that all the notifications under Article 103(1) of the EEA Agreement have been made (*1).


Article 4
This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union.




Done at Brussels, 14 March 2025.


For the EEA Joint Committee


The President

Nicolas VON LINGEN
            





(1)  
            OJ L, 2024/2221, 9.9.2024, ELI: http://data.europa.eu/eli/reg_impl/2024/2221/oj.

(2)  
            OJ L, 2024/2390, 9.9.2024, ELI: http://data.europa.eu/eli/reg_impl/2024/2390/oj.

(*1)  No constitutional requirements indicated.


ELI: http://data.europa.eu/eli/dec/2025/1034/oj
ISSN 1977-0677 (electronic edition)